Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

dc.contributor.author	Fernandez Castroagudin, Javier
dc.date.accessioned	2017-06-07T07:17:39Z
dc.date.available	2017-06-07T07:17:39Z
dc.date.issued	2012
dc.identifier.issn	1527-6465
dc.identifier.uri	http://hdl.handle.net/20.500.11940/4787
dc.language.iso	eng
dc.title	Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
dc.type	Artigo	es
dc.authorsophos	Gomez-Martin, C
dc.authorsophos	Bustamante, J
dc.authorsophos	Castroagudin, J F
dc.authorsophos	Salcedo, M
dc.authorsophos	Garralda, E
dc.authorsophos	Testillano, M
dc.authorsophos	Herrero, I
dc.authorsophos	Matilla, A
dc.authorsophos	Sangro, B
dc.identifier.doi	10.1002/lt.22434
dc.identifier.isi	:000298483100007
dc.identifier.pmid	21932373
dc.identifier.sophos	7921
dc.issue.number	1
dc.journal.title	LIVER TRANSPLANTATION
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Dixestivo
dc.page.initial	45
dc.page.final	52
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	18

Files in this item

Files	Size	Format	View
There are no files associated with this item.